Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 608-616

  Yousefi, Forouzan ^a   Ebtekar, Massoumeh ^a   Soleimani, Masoud ^a   Soudi, Sara ^b   Hashemi, Seyed Mahmoud ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

Author keywords

Experimental autoimmune encephalomyelitis; Immunomudulation; Mesenchymal stem cells; Regulatory T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOMUDULATION; MESENCHYMAL STEM CELLS; REGULATORY T CELLS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BRAIN; CELL DIFFERENTIATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOMODULATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; OSTEOCYTES; SPLEEN; TRANSPLANTATION IMMUNOLOGY;

EID: 84883618960     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.07.016     Document Type: Article

References (49)

1. D.W. Anderson, J.H. Ellenberg, C.M. Leventhal, S.C. Reingold, M. Rodriguez, and D.H. Silberberg Revised estimate of the prevalence of multiple sclerosis in the United States Ann Neurol 31 1992 333 336
2. B. Kornek, and H. Lassmann Neuropathology of multiple sclerosis - new concepts Brain Res Bull 61 2003 321 326 (Pubitemid 36952478)
3. T.J. Murray The history of multiple sclerosis: the changing frame of the disease over the centuries J Neurol Sci 277 Suppl. 1 2009 S3 S8
4. R.M. Ransohoff Animal models of multiple sclerosis: the good, the bad and the bottom line Nat Neurosci 15 2012 1074 1077
5. D. Furlani, M. Ugurlucan, L. Ong, K. Bieback, E. Pittermann, and I. Westien Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy Microvasc Res 77 2009 370 376
6. E. Mix, H. Meyer-Rienecker, and U.K. Zettl Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations J Neurol 255 Suppl. 6 2008 7 14
7. M. Matysiak, W. Orlowski, M. Fortak-Michalska, A. Jurewicz, and K. Selmaj Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2 J Neuroimmunol 233 2011 106 111
8. M.A. Coleman, and R.J. Steptoe Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease? Autoimmun Rev 12 2012 195 203
9. J.S. Lunn, S.A. Sakowski, J. Hur, and E.L. Feldman Stem cell technology for neurodegenerative diseases Ann Neurol 70 2011 353 361
10. M. Baker Stem cells and neurodegenerative disease: cool science and scepticism 2009
11. S. Pluchino, A. Quattrini, E. Brambilla, A. Gritti, G. Salani, and G. Dina Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis Nature 422 2003 688 694 (Pubitemid 36514101)
12. S. Pluchino, L. Zanotti, B. Rossi, E. Brambilla, L. Ottoboni, and G. Salani Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism Nature 436 2005 266 271 (Pubitemid 41021278)
13. Y.-C. Hsu, D.-C. Lee, and I.-M. Chiu Neural stem cells, neural progenitors, and neurotrophic factors Cell Transplant 16 2007 133 150 (Pubitemid 46668789)
14. B. Blum, and N. Benvenisty Clonal analysis of human embryonic stem cell differentiation into teratomas Stem Cells 25 2007 1924 1930 (Pubitemid 47258170)
15. B. Blum, and N. Benvenisty The tumorigenicity of human embryonic stem cells Adv Cancer Res 100 2008 133 158 (Pubitemid 351932182)
16. H. Hentze, P.L. Soong, S.T. Wang, B.W. Phillips, T.C. Putti, and N.R. Dunn Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies Stem Cell Res 2 2009 198 210
17. K. Lee, M.K. Majumdar, D. Buyaner, J.K. Hendricks, M.F. Pittenger, and J.D. Mosca Human mesenchymal stem cells maintain transgene expression during expansion and differentiation Mol Ther 3 2001 857 866 (Pubitemid 32611295)
18. M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, and E. Simpson Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood 101 2003 3722 3729 (Pubitemid 36857965)
19. R.K. Burt, B.A. Cohen, E. Russell, K. Spero, A. Joshi, and Y. Oyama Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores Blood 102 2003 2373 2378 (Pubitemid 37193572)
20. J.S. Draper, K. Smith, P. Gokhale, H.D. Moore, E. Maltby, and J. Johnson Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells Nat Biotechnol 22 2004 53 54 (Pubitemid 38057956)
21. A. Augello, R. Tasso, S.M. Negrini, A. Amateis, F. Indiveri, and R. Cancedda Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway Eur J Immunol 35 2005 1482 1490 (Pubitemid 40691430)
22. R. Saccardi, T. Kozak, C. Bocelli-Tyndall, A. Fassas, A. Kazis, and E. Havrdova Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Mult Scler 12 2006 814 823 (Pubitemid 46111776)
23. A. Uccelli, A. Laroni, and M.S. Freedman Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases Lancet Neurol 10 2011 649 656
24. M. El-behi, A. Rostami, and B. Ciric Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis J Neuroimmune Pharmacol 5 2010 189 197
25. A. Uccelli, and D.J. Prockop Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 22 2010 768 774
26. S. Morando, T. Vigo, M. Esposito, S. Casazza, G. Novi, and M.C. Principato The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms Stem Cell Res Ther 3 2012 3
27. D.J. Prockop, D.J. Kota, N. Bazhanov, and R.L. Reger Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) J Cell Mol Med 14 2010 2190 2199
28. X. Qu, X. Liu, K. Cheng, R. Yang, and R.C. Zhao Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion Exp Hematol 40 2012 761 770
29. M.M. Zafranskaya, D.B. Nizheharodova, M.Y. Yurkevich, N.V. Lamouskaya, Y.M. Motuzova, and S.S. Bagatka In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients Immunol Lett 149 2013 9 18
30. B.A. Bunnell, M. Flaat, C. Gagliardi, B. Patel, and C. Ripoll Adipose-derived stem cells: isolation, expansion and differentiation Methods 45 2008 115 120 (Pubitemid 351885360)
31. M.J. Gimble, B.A. Bunnell, E.S. Chiu, and F. Guilak Concise review: adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation Stem Cells 29 2011 749 754
32. J. Zhang, Y. Li, Y. Cui, J. Chen, M. Lu, and S.B. Elias Erythropoietin treatment improves neurological functional recovery in EAE mice Brain Res 1034 2005 34 39 (Pubitemid 40248517)
33. I. Kochetkova, T. Thornburg, G. Callis, and D.W. Pascual Segregated regulatory CD39 + CD4 + T cell function: TGF-beta-producing Foxp3- and IL-10-producing Foxp3 + cells are interdependent for protection against collagen-induced arthritis J Immunol 187 2011 4654 4666
34. T. Wilson, C. Stark, J. Holmbom, A. Rosling, A. Kuusilehto, and T. Tirri Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal J Tissue Eng 2010 2010 345806
35. N.L. Payne, G. Sun, C. McDonald, D. Layton, L. Moussa, and A. Emerson-Webber Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination Cell Transplant 22 2013 1409 1425
36. S.M. Hashemi, Z.M. Hassan, A.A. Pourfathollah, S. Soudi, A. Shafiee, and M. Soleimani Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB/c, C57BL/6, and DBA mouse strains J Cell Biochem 114 2013 955 965
37. G. Ocklind Stimulation of human lymphocytes by phytohemagglutinin (PHA) in a new ultra-microtest plate Immunobiology 171 1986 339 344 (Pubitemid 16049298)
38. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, and E. Gerdoni Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761 (Pubitemid 41208591)
39. G. Constantin, S. Marconi, B. Rossi, S. Angiari, L. Calderan, and E. Anghileri Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis Stem Cells 27 2009 2624 2635
40. I.M. Barbash, P. Chouraqui, J. Baron, M.S. Feinberg, S. Etzion, and A. Tessone Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution Circulation 108 2003 863 868 (Pubitemid 37022130)
41. R.H. Lee, A.A. Pulin, M.J. Seo, D.J. Kota, J. Ylostalo, and B.L. Larson Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 Cell Stem Cell 5 2009 54 63
42. M. Laan, Z.H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, and D.C. Gruenert Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways J Immunol 162 1999 2347 2352 (Pubitemid 29288861)
43. M. Rafei, P.M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, and E. Birman Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner J Immunol 182 2009 5994 6002
44. V. Brucklacher-Waldert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis Brain 132 2009 3329 3341
45. R.A. O'Connor, and S.M. Anderton Foxp3 + regulatory T cells in the control of experimental CNS autoimmune disease J Neuroimmunol 193 2008 1 11
46. Z. Zhao, Z. Wang, Q. Li, W. Li, Y. You, and P. Zou The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes PLoS One 7 2012 e45675
47. D.O. Zubov Immunoregulatory role of mesenchymal stem cells in bone reparation processes Fiziol Zh 54 2008 30 36
48. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506 (Pubitemid 350159613)
49. R. Izadpanah, C. Trygg, B. Patel, C. Kriedt, J. Dufour, and J.M. Gimble Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue J Cell Biochem 99 2006 1285 1297